Cargando…

Development of World Health Organization (WHO) recommendations for appropriate clinical trial endpoints for next-generation Human Papillomavirus (HPV) vaccines

The World Health Organization (WHO) serves as a key organization to bring together experts along the continuum of vaccine development and regulatory approval, among its other functions. Using the revision of WHO's guidelines on prophylactic human papillomavirus (HPV) vaccine as an example, we d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prabhu, Malavika, Eckert, Linda O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886904/ https://www.ncbi.nlm.nih.gov/pubmed/29074180 http://dx.doi.org/10.1016/j.pvr.2016.10.002

Ejemplares similares

Are the Currently Existing Anti-Human Papillomavirus Vaccines Appropriate for the Developing World?
por: van Bogaert, LJ
Publicado: (2013)

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development
por: Ahmels, Melinda, et al.
Publicado: (2022)

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
por: Petrosky, Emiko, et al.
Publicado: (2015)

B Cell Responses upon Human Papillomavirus (HPV) Infection and Vaccination
por: Prabhu, Priya R., et al.
Publicado: (2022)

Study of methods for endpoint aware inspection in a next generation firewall
por: Heino, Jenny, et al.
Publicado: (2022)

Human papillomavirus spectrum of HPV-infected women in Nigeria: an analysis by next-generation sequencing and type-specific PCR
por: Dom-Chima, Ngozi, et al.
Publicado: (2023)

Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females
por: Harper, Diane M., et al.
Publicado: (2011)

Genotyping of high-risk anal human papillomavirus (HPV): ion torrent-next generation sequencing vs. linear array
por: Nowak, Rebecca G., et al.
Publicado: (2017)

The next generation of the World Health Organization's global antiretroviral guidance
por: Hirnschall, Gottfried, et al.
Publicado: (2013)

Appropriate human papillomavirus vaccination strategies – Authors' reply
por: Michels, Karin B, et al.
Publicado: (2009)

Would Chinese Men Who Have Sex With Men Take Up Human Papillomavirus (HPV) Screening as an Alternative Prevention Strategy to HPV Vaccination?
por: Chan, Paul Shing-fong, et al.
Publicado: (2022)

Predictive impact of human papillomavirus circulating tumor DNA in treatment response monitoring of HPV‐associated cancers; a meta‐analysis on recurrent event endpoints
por: Karimi, Abbas, et al.
Publicado: (2023)

Individual- and Regional-level determinants of Human Papillomavirus (HPV) vaccine refusal: the Ontario Grade 8 HPV vaccine cohort study
por: Remes, Olivia, et al.
Publicado: (2014)

Recommendations on e-infrastructures for next-generation sequencing
por: Spjuth, Ola, et al.
Publicado: (2016)

HPV Population Profiling in Healthy Men by Next-Generation Deep Sequencing Coupled with HPV-QUEST
por: Yin, Li, et al.
Publicado: (2016)

Barriers and Facilitators of Romanian HPV (Human Papillomavirus) Vaccination
por: Manolescu, Loredana Sabina Cornelia, et al.
Publicado: (2022)

Appropriate Surrogate Endpoint in Drug-Coated Balloon Trials for Coronary Artery Diseases
por: Lang, Xinyue, et al.
Publicado: (2022)

The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials
por: Thorlund, Kristian, et al.
Publicado: (2023)

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction ()
por: Li, Anyie J., et al.
Publicado: (2022)

Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States
por: Meites, Elissa, et al.
Publicado: (2022)

Lack of school requirements and clinician recommendations for human papillomavirus vaccination
por: Niccolai, Linda M., et al.
Publicado: (2018)

Carcinogenic risk of human papillomavirus (HPV) genotypes and potential effects of HPV vaccines in Korea
por: Park, Eunhyang, et al.
Publicado: (2019)

Human Papillomavirus (HPV) Health Savings as an Alternative Solution: HPV Vaccination Behavior in Adolescents
por: Lismidiati, Wiwin, et al.
Publicado: (2021)

Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination
por: Osaghae, Ikponmwosa, et al.
Publicado: (2022)

Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population
por: Radecki Breitkopf, Carmen, et al.
Publicado: (2016)

Knowledge and Awareness of Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccine Among HPV-Infected Chinese Women
por: Baloch, Zulqarnain, et al.
Publicado: (2017)

Immunogenicity of next-generation HPV vaccines in non-human primates: Measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine
por: Gupta, Gaurav, et al.
Publicado: (2016)

World Health Organization recommends first malaria vaccine
por: Trottier, Helen, et al.
Publicado: (2021)

Predicting human papillomavirus vaccine uptake in men who have sex with men the influence of vaccine price and receiving an HPV diagnosis
por: Yao, Po-Yi, et al.
Publicado: (2022)

What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study
por: Landy, Rebecca, et al.
Publicado: (2017)

Aducanumab: Appropriate use recommendations
por: Cummings, Jeffrey, et al.
Publicado: (2021)

Aducanumab: Appropriate Use Recommendations
por: Cummings, J., et al.
Publicado: (2021)

Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19
por: McCaw, Zachary R., et al.
Publicado: (2020)

Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate Endpoints
por: Alkhouri, Naim, et al.
Publicado: (2019)

Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials
por: Wang, An, et al.
Publicado: (2023)

Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland
por: McCusker, Sarah M, et al.
Publicado: (2013)

Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea
por: Kim, Young-Tak, et al.
Publicado: (2018)

Knowledge and awareness of Human Papillomavirus (HPV) and HPV vaccines among Caribbean youth: the case of the Bahamas
por: George, Clemon, et al.
Publicado: (2019)

Knowledge of Human Papillomavirus (HPV) and Oropharyngeal Cancer and Acceptability of the HPV Vaccine among Dental Students
por: Farsi, Nada J, et al.
Publicado: (2020)

Useful pharmacodynamic endpoints in children: selection, measurement, and next steps
por: Kelly, Lauren E, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o9distjadnt63jhmi1aeq2bvsa